Global neuromodulation market is registering a healthy CAGR of 13.50% in the forecast period of 2019-2026. This rise in the market value can be attributed due to rise in geriatric population and their vulnerability to neurological disorders. The expansion in emerging economies is likely to drive the market growth.
Neuromodulation market research report can be utilized efficiently by both established and new players in the healthcare industry for absolute understanding of the market. What is more, such market report analyses and provides the historic data along with the current performance of the market. Their moves like product launches, joint ventures, mergers and acquisitions and the respective effect on the sales, import, export, revenue and CAGR values have been studied completely in the report. It is an entire background analysis of the industry, which includes an estimation of the parental market. This wide ranging Neuromodulation market report highlights the global key manufacturers, to define, describe and analyze the market competition landscape, based on SWOT analysis.
Download PDF Sample Copy of Report https://databridgemarketresearch.com/request-a-sample/?dbmr=global-neuromodulation-market
Some of the major players operating in neuromodulation market areBioAlps Association, Bioness Inc., Soterix Medical Inc., Medtronic, Abbott, Boston Scientific Corporation, LivaNova PLC, Axonics Modulation Technologies, Inc., Cochlear Ltd., MED-EL, Nevro Corp., Neuronetics, Cogentix Medical, Johnson & Johnson Services Inc., NeuroPace, Inc., NeuroSigma, Inc., NDI, IntraPace, Inc., DynaMD, BioControl Medical, Synapse Biomedical Inc., Functional Neuromodulation, Ltd., Stimwave LLC, Biegler GmbH, Stimwave LLC, Modulus, Inc. EnteroMedics Inc. and Integer Holdings Corporation among others.
Major market drivers and restraints:
Rise in geriatric population
Increase in cases of neurological diseases such as Alzheimer’s and Parkinson’s diseases
Increase in awareness regarding the safety and efficacy of neurostimulator devices
Robust product pipeline
Rise in investments and funds
Unfavorable reimbursement policies
Lack of healthcare professionals
Market Segmentation: Global Neuromodulation Market
The neuromodulation market is segmented by technology into internal neuromodulation and external neuromodulation (Non-invasive). Internal Neuromodulation is sub segmented into spinal cord stimulation (SCS), deep brain stimulation (DBS), vagus nerve stimulation (VNS), sacral nerve stimulation (SNS) and gastric electrical stimulation (GES).External neuromodulation (non-invasive) is sub segmented into transcutaneous electrical nerve stimulation (TENS), transcranial magnetic stimulation (TMS) and respiratory electrical stimulation (RES).
On the basis of application the market is segmented into spinal cord stimulation (SCS), deep brain stimulation (DBS), sacral nerve stimulation market, vagus nerve stimulation market, gastric electrical stimulation market, transcutaneous electrical nerve stimulation market, repetitive transcranial magnetic stimulation market and respiratory electrical stimulation market.
Spinal cord stimulation (SCS) market is further sub segmented by application into failed back syndrome (FBSS), chronic pain and ischemia. Deep brain stimulation (DBS) marketis further sub segmented by application into Parkinson’s disease, tremor and depression. Sacral Nerve Stimulation Marketis further sub segmented by application into urine incontinence and fecal incontinence.Vagus Nerve Stimulation Marketis further sub segmented by application intoepilepsy and others.Gastric electrical stimulation market is further sub segmented by application intogastroparesis and obesity.Transcutaneous electrical nerve stimulation market is further sub segmented by application into treatment resistant depression and others. Repetitive transcranial magnetic stimulation market is further sub segmented by application into depression and migraine headache.Respiratory electrical stimulation market is further sub segmented by application into spinal cord injury.
On the basis of geography, neuromodulation market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, andBrazil among others. In 2017, North America is expected to dominate the market.
Request an analyst call at https://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-neuromodulation-market
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.
Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Data Bridge Market Research
Email: [email protected]